Evotec SE

Company Profile

Business Description

Evotec SE is a drug discovery company that specializes in platform-based solutions for pharmaceutical and biotechnology collaborators worldwide. Operating through two main segments—EVT Execute and EVT Innovate—the company provides integrated drug discovery services on a fee-for-service basis, supplemented by performance-based commercial structures including milestone payments and royalties. The EVT Execute segment delivers stand-alone or integrated solutions for target identification and validation, while the company continues to shift toward technology licensing and asset-lighter business models, particularly in biologics manufacturing. Evotec maintains a focus on co-owned assets and long-term strategic collaborations with major pharmaceutical partners. Founded in Hamburg, Germany, the company trades on NASDAQ under the symbol EVO and on the Frankfurt Stock Exchange under EVT, serving clients across the global pharmaceutical and biotechnology industries through its specialized expertise in early-stage drug development.

Profitability & Growth

Balance Sheet Snapshot

Stock Statistics